Logo image of SERI.MI

SERI INDUSTRIAL SPA (SERI.MI) Stock Fundamental Analysis

BIT:SERI - Euronext Milan - IT0005283640 - Common Stock - Currency: EUR

2.46  +0.2 (+8.85%)

Fundamental Rating

3

Taking everything into account, SERI scores 3 out of 10 in our fundamental rating. SERI was compared to 65 industry peers in the Chemicals industry. Both the profitability and financial health of SERI have multiple concerns. While showing a medium growth rate, SERI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SERI has reported negative net income.
SERI had a positive operating cash flow in the past year.
In the past 5 years SERI reported 4 times negative net income.
SERI had a positive operating cash flow in 4 of the past 5 years.
SERI.MI Yearly Net Income VS EBIT VS OCF VS FCFSERI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

SERI has a Return On Assets of -2.46%. This is in the lower half of the industry: SERI underperforms 64.62% of its industry peers.
The Return On Equity of SERI (-8.71%) is worse than 67.69% of its industry peers.
Industry RankSector Rank
ROA -2.46%
ROE -8.71%
ROIC N/A
ROA(3y)-1.44%
ROA(5y)-1.02%
ROE(3y)-4.5%
ROE(5y)-3.16%
ROIC(3y)N/A
ROIC(5y)N/A
SERI.MI Yearly ROA, ROE, ROICSERI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

The Gross Margin of SERI (50.22%) is better than 75.38% of its industry peers.
SERI's Gross Margin has improved in the last couple of years.
SERI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.34%
SERI.MI Yearly Profit, Operating, Gross MarginsSERI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

3

2. Health

2.1 Basic Checks

SERI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SERI has been increased compared to 1 year ago.
The number of shares outstanding for SERI has been increased compared to 5 years ago.
Compared to 1 year ago, SERI has an improved debt to assets ratio.
SERI.MI Yearly Shares OutstandingSERI.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
SERI.MI Yearly Total Debt VS Total AssetsSERI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.67, we must say that SERI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SERI (0.67) is worse than 81.54% of its industry peers.
SERI has a debt to FCF ratio of 2.53. This is a good value and a sign of high solvency as SERI would need 2.53 years to pay back of all of its debts.
The Debt to FCF ratio of SERI (2.53) is better than 89.23% of its industry peers.
SERI has a Debt/Equity ratio of 0.58. This is a neutral value indicating SERI is somewhat dependend on debt financing.
The Debt to Equity ratio of SERI (0.58) is worse than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.53
Altman-Z 0.67
ROIC/WACCN/A
WACC6.89%
SERI.MI Yearly LT Debt VS Equity VS FCFSERI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M -100M

2.3 Liquidity

A Current Ratio of 1.39 indicates that SERI should not have too much problems paying its short term obligations.
SERI has a worse Current ratio (1.39) than 69.23% of its industry peers.
SERI has a Quick Ratio of 1.39. This is a bad value and indicates that SERI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SERI (0.85) is worse than 73.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.85
SERI.MI Yearly Current Assets VS Current LiabilitesSERI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.22% over the past year.
The Revenue for SERI has decreased by -38.31% in the past year. This is quite bad
The Revenue has been growing slightly by 7.16% on average over the past years.
EPS 1Y (TTM)29.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.29%
Revenue 1Y (TTM)-38.31%
Revenue growth 3Y9.82%
Revenue growth 5Y7.16%
Sales Q2Q%-9.79%

3.2 Future

SERI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.89% yearly.
SERI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.26% yearly.
EPS Next Y-89.36%
EPS Next 2Y-14.18%
EPS Next 3Y18.89%
EPS Next 5YN/A
Revenue Next Year5.44%
Revenue Next 2Y27%
Revenue Next 3Y23.26%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SERI.MI Yearly Revenue VS EstimatesSERI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
SERI.MI Yearly EPS VS EstimatesSERI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

SERI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SERI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SERI.MI Price Earnings VS Forward Price EarningsSERI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SERI is valued a bit cheaper than 63.08% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SERI is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.75
EV/EBITDA 9.19
SERI.MI Per share dataSERI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

SERI's earnings are expected to grow with 18.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.18%
EPS Next 3Y18.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SERI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SERI INDUSTRIAL SPA

BIT:SERI (6/6/2025, 3:09:46 PM)

2.46

+0.2 (+8.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.71%
Inst Owner ChangeN/A
Ins Owners56.47%
Ins Owner ChangeN/A
Market Cap132.79M
Analysts80
Price Target5.41 (119.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.84
P/FCF 2.75
P/OCF 1.54
P/B 1.07
P/tB 3.86
EV/EBITDA 9.19
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)0.89
FCFY36.36%
OCF(TTM)1.59
OCFY64.76%
SpS2.93
BVpS2.3
TBVpS0.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.46%
ROE -8.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.22%
FCFM 30.56%
ROA(3y)-1.44%
ROA(5y)-1.02%
ROE(3y)-4.5%
ROE(5y)-3.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.34%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.53
Debt/EBITDA 3.57
Cap/Depr 130.41%
Cap/Sales 23.87%
Interest Coverage N/A
Cash Conversion 425.53%
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.85
Altman-Z 0.67
F-Score6
WACC6.89%
ROIC/WACCN/A
Cap/Depr(3y)99.27%
Cap/Depr(5y)161.41%
Cap/Sales(3y)13.79%
Cap/Sales(5y)17.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.29%
EPS Next Y-89.36%
EPS Next 2Y-14.18%
EPS Next 3Y18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.31%
Revenue growth 3Y9.82%
Revenue growth 5Y7.16%
Sales Q2Q%-9.79%
Revenue Next Year5.44%
Revenue Next 2Y27%
Revenue Next 3Y23.26%
Revenue Next 5YN/A
EBIT growth 1Y21.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year242.99%
EBIT Next 3Y94.52%
EBIT Next 5Y55.53%
FCF growth 1Y303.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1380.45%
OCF growth 3Y357.92%
OCF growth 5Y56.2%